Page last updated: 2024-10-30

metaproterenol and Premenstrual Syndrome

metaproterenol has been researched along with Premenstrual Syndrome in 1 studies

Metaproterenol: A beta-2 adrenergic agonist used in the treatment of ASTHMA and BRONCHIAL SPASM.
orciprenaline : A racemate composed of equimolar amounts of (R)- and (S)-orciprenaline. Used (as its sulfate salt) to relax the airway muscles and improve breathing for patients suffering from asthma or bronchitis.
5-[1-hydroxy-2-(isopropanylamino)ethyl]benzene-1,3-diol : A member of the class of resorcinols bearing an additional 1-hydroxy-2-(isopropanylamino)ethyl substituent at position 5 of resorcinol itself.

Premenstrual Syndrome: A combination of distressing physical, psychologic, or behavioral changes that occur during the luteal phase of the menstrual cycle. Symptoms of PMS are diverse (such as pain, water-retention, anxiety, cravings, and depression) and they diminish markedly 2 or 3 days after the initiation of menses.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eliasson, O1
Longo, M1
Dore-Duffy, P1
Densmore, MJ1
DeGraff, AC1

Trials

1 trial available for metaproterenol and Premenstrual Syndrome

ArticleYear
Serum 13-14-diOH-15-keto-prostaglandin F2 alpha and airway response to meclofenamate and metaproterenol in relation to the menstrual cycle.
    The Journal of asthma : official journal of the Association for the Care of Asthma, 1986, Volume: 23, Issue:6

    Topics: Adult; Asthma; Clinical Trials as Topic; Dinoprost; Double-Blind Method; Female; Humans; Meclofenami

1986
chemdatabank.com